Then cells were harvested by centrifugation and washed twice with ice-cold PBS (pH 7.4). The cells were fixed in ice-cold 70% ethanol at least for

24 h at 4°C. Next, the cells were washed twice with PBS and resuspended in lml DNA staining solution (50 μg/ml propidium iodide(PI) and 100 μg/ml RNase A in PBS)for 30 min. Analysis of cell cycle distribution was performed by Flow Cytometer and analyzed by Cell Quest software Panobinostat clinical trial package. Every experiment was repeated three times. Image analysis The image analysis for RT-PCR and Western blot were performed by Quantity One 4.5 image analytical system, optical density ratio(ODR) of strap indicated as follow: TNF-alpha inhibitor ODRMta1: MTA1/18SrRNA, ODRE: ER alpha/β-Actin, ODRMMP-9: MMP-9/β-Actin, ODRC:CyclinD1/β-Actin. Statistical analysis The statistical significance of differences in mean values was assessed using Student’s t test with SPSS 11.0 statistic

software. P < 0.05 was considered statistically significant. Average values were expressed as mean ± standard deviation (SD). Results The construction of pGenesil-1/MTA1 shRNA expression plasmid The recombinant plasmids were cut off by restriction enzyme Xba, BamHIand HindIII, The band about 66 bp was cut off using BamHIand HindIII; on 0.8% agarose gel electrophoresis, the band about 342 bp was cut off using XbaIand BamHI, the band about 408 bp was cut off using XbaIand HindIII (Figure 1). The results of incision with restriction endonucleases and sequencing showed Ketotifen correct plasmids. Figure 1 Restrictive enzyme incision analysis for pGensil-1/MTA1 shRNA plasmid using RT-PCR. M: DNA Marker. lane 1: pGenesil-1/MTA1 shRNA(pGM1) plasmid was cut selleckchem off by BamHI and HindIII. lane 2: pGenesil-1/MTA1 shRNA(pGM1) plasmid was cut off by BamHI and XbaI.lane 3: pGenesil-1/MTA1 shRNA(pGM1)

plasmid was cut off by HindIII and XbaI. lane 4: pGenesil-1/MTA1 shRNA(pGM2) plasmid was cut off by BamHI and HindIII. lane 5: pGenesil-1/MTA1 shRNA(pGM2) plasmid was cut off by BamHI and XbaI. lane 6: pGenesil-1/MTA1 shRNA(pGM2) plasmid was cut off by HindIII and XbaI. Observation of transfection results After transfection with the recombinant plasmid, the breast cancer cell lines MDA-MB-231 and MCF-7 showed green luminescence(green fluorescent protein, GFP), suggesting the correct expression of pGenesil-1/MTA1 shRNA (Figure 2). Figure 2 The expression of GFP in breast cancer cells MDA-MB-231 and MCF-7 transfected with pGenesil-1/MTA1 shRNA recombinant plasmids under fluorescent microscope. A. MDA-MB-231 cells transfected with pGenesil-1/MTA1 shRNA plasmids for 36 h. B. MCF-7 cells transfected with pGenesil-1/MTA1 shRNA plasmids for 36 h. ShRNA targeting MTA1 inhibited MTA1 mRNA expression in MDA-MB-231 and MCF-7 cells The mRNA expression intensities of goal genes, inhibited by specific shRNAs in the breast cancer cells MDA-MB-231 and MCF-7, were analyzed by semiquantitive RT-PCR.